Solid-phase biological assays for drug discovery

Annu Rev Anal Chem (Palo Alto Calif). 2014:7:337-59. doi: 10.1146/annurev-anchem-071213-020241. Epub 2014 Jun 5.

Abstract

In the past 30 years, there has been a significant growth in the use of solid-phase assays in the area of drug discovery, with a range of new assays being used for both soluble and membrane-bound targets. In this review, we provide some basic background to typical drug targets and immobilization protocols used in solid-phase biological assays (SPBAs) for drug discovery, with emphasis on particularly labile biomolecular targets such as kinases and membrane-bound receptors, and highlight some of the more recent approaches for producing protein microarrays, bioaffinity columns, and other devices that are central to small molecule screening by SPBA. We then discuss key applications of such assays to identify drug leads, with an emphasis on the screening of mixtures. We conclude by highlighting specific advantages and potential disadvantages of SPBAs, particularly as they relate to particular assay formats.

Keywords: bioaffinity chromatography; kinases; membrane proteins; protein microarrays.

Publication types

  • Review

MeSH terms

  • Animals
  • Biological Assay / methods*
  • Drug Discovery*
  • High-Throughput Screening Assays / methods*
  • Humans
  • Protein Array Analysis / methods*
  • Small Molecule Libraries / analysis*
  • Small Molecule Libraries / chemistry

Substances

  • Small Molecule Libraries